Table 2 Prevalence of prescription and over-the-counter medication usage
Medication | Category | Total sample (n = 97) | (OPC Synergy® + Catalyn®) (n = 31) | (Ginkgo Synergy® + Choline) (n = 33) | Placebo (n = 33) | Statistic | |
|---|---|---|---|---|---|---|---|
Current prescription | Anti-depressant | Yes | 11 (11.3%) | 6 (19.4%) | 1 (3%) | 4 (12.1%) | X 2(2) = 4.3, p = 0.12 |
No | 86 (88.7%) | 25 (80.6%) | 32 (97%) | 29 (87.9%) | |||
Beta blocker | Yes | 7 (7.2%) | 4 (12.9%) | 3 (9.1%) | - | X 2(2) = 4.2, p = 0.12 | |
No | 90 (92.8%) | 27 (87.1%) | 30 (90.1%) | 33 (100%) | |||
Anti-hypertensive | Yes | 25 (25.8%) | 9 (29%) | 9 (27.3%) | 7 (21.2%) | X 2(2) = 0.6, p = 0.75 | |
No | 72 (74.2%) | 22 (71%) | 24 (72.2%) | 26 (78.8%) | |||
Anti-hypercholesterol | Yes | 11 (11.3%) | 7 (22.6%) | 1 (3%) | 3 (9.1%) | X 2(2) = 6.3, p = 0.04 | |
No | 86 (88.7%) | 19 (77.4%) | 32 (97%) | 30 (90.1%) | |||
Laxative | Yes | 7 (7.2%) | 2 (6.5%) | 3 (9.1%) | 2 (6.1%) | X 2(2) = 0.3, p = 0.88 | |
No | 90 (92.8%) | 29 (93.5%) | 30 (90.1%) | 31 (93.9%) | |||
Insomnia | Yes | 10 (10.3%) | 3 (9.7%) | 4 (12.1%) | 3 (9.1%) | X 2(2) = 0.2, p = 0.91 | |
No | 87 (89.7%) | 28 (90.3%) | 29 (87.9%) | 30 (90.1%) | |||
OTC in the prior week | Aspirin | Yes | 33 (34%) | 10 (32.3%) | 14 (42.4%) | 9 (27.3%) | X 2(2) = 1.8, p = 0.42 |
No | 64 (66%) | 21 (67.7%) | 19 (57.6%) | 24 (72.2%) | |||
Tylenol | Yes | 34 (35.1%) | 12 (38.7%) | 13 (39.4%) | 9 (27.3%) | X 2(2) = 1.3, p = 0.51 | |
No | 63 (64.9%) | 19 (61.3%) | 20 (60.6%) | 24 (72.2%) | |||
Antacid | Yes | 13 (13.4%) | 6 (19.4%) | 5 (15.2%) | 2 (6.1%) | X 2(2) = 2.6, p = 0.28 | |
No | 84 (86.6%) | 25 (80.6%) | 28 (84.8%) | 31 (93.9%) | |||
Vitamin/mineral | Yes | 67 (69.1%) | 21 (67.7%) | 25 (75.8%) | 21 (63.6%) | X 2(2) = 1.2, p = 0.56 | |
No | 30 (30.9%) | 10 (32.3%) | 8 (24.2%) | 12 (36.4%) | |||